These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B, Mayer G, Yilmaz N, Skvarilova L, Spinar J, Vitovec J, Toman J, Woloszcuk W, Stanek B. Wien Klin Wochenschr; 1998 Feb 13; 110(3):89-95. PubMed ID: 9553203 [Abstract] [Full Text] [Related]
9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group. Clin Ther; 2008 Mar 13; 30(3):482-98. PubMed ID: 18405787 [Abstract] [Full Text] [Related]
12. Functional role of endogenous adenosine in human chronic renal disease. Balakrishnan VS, Coles GA, Williams JD. Exp Nephrol; 1996 Mar 13; 4(1):26-36. PubMed ID: 8788597 [Abstract] [Full Text] [Related]
14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651 [Abstract] [Full Text] [Related]
15. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Circulation; 2004 Mar 09; 109(9):1186-93. PubMed ID: 14981006 [Abstract] [Full Text] [Related]
16. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Dhaun N, Macintyre IM, Melville V, Lilitkarntakul P, Johnston NR, Goddard J, Webb DJ. Hypertension; 2009 Jul 09; 54(1):113-9. PubMed ID: 19506099 [Abstract] [Full Text] [Related]
17. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Neuhofer W, Pittrow D. Eur J Clin Invest; 2009 Jun 09; 39 Suppl 2():50-67. PubMed ID: 19335747 [Abstract] [Full Text] [Related]
18. Endothelin-1 in chronic renal failure and hypertension. Larivière R, Lebel M. Can J Physiol Pharmacol; 2003 Jun 09; 81(6):607-21. PubMed ID: 12839272 [Abstract] [Full Text] [Related]